Viewing Study NCT05404204


Ignite Creation Date: 2025-12-24 @ 9:16 PM
Ignite Modification Date: 2026-01-01 @ 1:45 PM
Study NCT ID: NCT05404204
Status: UNKNOWN
Last Update Posted: 2022-06-03
First Post: 2022-05-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Efficacy and Safety of a Novel Adjunctive Pacing Strategy During Rotational Atherectomy
Sponsor: Vancouver Island Health Authority
Organization:

Study Overview

Official Title: Strategy to ROTAblate and PACE (ROTA-PACE) Study
Status: UNKNOWN
Status Verified Date: 2022-05
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ROTA-PACE
Brief Summary: Coronary artery narrowings interfere with blood flow to the heart which can cause chest pain and heart attacks. Cardiologists can treat these narrowings with balloons and stents. However, some narrowings can become very calcified and hard making treatment with balloons and stents difficult. Rotational atherectomy is a tool to treat calcific coronary disease. It uses an ablative drill to break down the hardened plaques inside the coronary arteries facilitating subsequent treatment with balloons and stents. However, during this procedure patients can experience a slow heart rate which may compromise procedural safety. Cardiologists may use a temporary pacemaker that is inserted by separately accessing the heart through a large vein usually from the leg. This maintains a safe heart rate throughout the procedure. However, inserting the temporary pacemaker is associated with additional complications. We have developed and propose an alternative strategy to provide a temporary safety pacemaker during rotational atherectomy without the need for inserting an additional pacemaker.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: